SENS
Senseonics Holdings, Inc.
$5.05
-1.56
(-23.54%)
Mkt Cap
214.20M
Volume
4,937,171
52W Range
5.07-15.2
Sector
Healthcare
Beta
1.05
EPS (TTM)
-1.85
P/E Ratio
-3.33
Revenue (TTM)
36.91M
Rev Growth (5Y)
+48.1%
EPS Growth (5Y)
N/A
Company Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.26M | 22.47M | 22.39M | 16.39M | 13.68M | 4.95M | 21.30M | 18.91M | 6.37M | 332,000 | 38,000 | 0 |
| Net Income | (69.11M) | (78.62M) | (60.39M) | 142.12M | (302.47M) | (175.17M) | (115.55M) | (93.97M) | (59.10M) | (43.93M) | (29.88M) | (18.89M) |
| EPS | -1.66 | -2.50 | -2.20 | 6.00 | -14.40 | -15.40 | -12.20 | -12.00 | -10.20 | -9.80 | -6.60 | -4.20 |
| Free Cash Flow | (60.24M) | (62.70M) | (70.51M) | (66.62M) | (56.29M) | (67.60M) | (137.09M) | (91.76M) | (56.08M) | (38.49M) | N/A | N/A |
| FCF / Share | -1.44 | -1.99 | -2.48 | -2.85 | -2.67 | -5.93 | -14.53 | -11.66 | -9.67 | -8.63 | N/A | N/A |
| Operating CF | (59.13M) | (60.47M) | (70.16M) | (66.31M) | (56.08M) | (67.42M) | (136.05M) | (90.77M) | (55.74M) | (38.02M) | N/A | N/A |
| Total Assets | 126.27M | 100.44M | 138.22M | 177.67M | 198.93M | 35.92M | 132.80M | 159.97M | 45.94M | 22.27M | N/A | N/A |
| Total Debt | 41.37M | 61.05M | 47.78M | 75.38M | 64.21M | 62.70M | 118.56M | 50.97M | 24.48M | 19.22M | N/A | N/A |
| Cash & Equiv | 40.55M | 74.60M | 75.71M | 35.79M | 33.46M | 18.00M | 95.94M | 136.79M | 16.15M | 13.05M | N/A | N/A |
| Book Value | 61.05M | (16.55M) | 35.80M | (2.58M) | (185.53M) | (144.08M) | (8.65M) | 71.26M | 7.27M | (4.88M) | N/A | N/A |
| Return on Equity | -1.13 | N/A | -1.69 | N/A | N/A | N/A | N/A | -1.32 | -8.13 | N/A | N/A | N/A |
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.26M | 8.10M | 8.30M | 6.26M | 8.30M | 4.26M | 4.87M | 5.05M | 8.03M | 6.10M | 4.13M | 4.14M |
| Net Income | (20.82M) | (19.53M) | (15.48M) | (14.26M) | (15.48M) | (23.98M) | (20.29M) | (18.88M) | (17.19M) | (24.10M) | (20.42M) | 1.32M |
| EPS | -0.50 | -0.43 | -0.52 | -0.40 | -0.46 | -0.77 | -0.66 | -0.61 | -0.65 | -0.81 | -0.72 | 0.05 |
| Free Cash Flow | (23.25M) | (15.98M) | (9.39M) | (16.51M) | (14.28M) | (14.61M) | (13.23M) | (20.58M) | (14.99M) | (17.39M) | (17.98M) | (19.91M) |
| FCF / Share | -0.56 | -0.36 | -0.32 | -0.46 | -0.43 | -0.47 | -0.43 | -0.67 | -0.57 | -0.59 | -0.63 | -0.80 |
| Operating CF | (22.94M) | (15.82M) | (9.27M) | (16.08M) | (14.25M) | (14.81M) | (11.14M) | (20.26M) | (14.82M) | (17.26M) | (17.98M) | (19.85M) |
| Total Assets | 126.27M | 139.92M | 150.27M | 87.21M | 100.44M | 96.33M | 111.56M | 126.52M | 138.22M | 154.06M | 153.36M | 158.53M |
| Total Debt | 41.37M | 41.16M | 41.24M | 41.08M | 61.05M | 60.14M | 59.25M | 58.40M | 47.78M | 47.21M | 39.59M | 40.72M |
| Cash & Equiv | 40.55M | 34.77M | 31.52M | 39.31M | 74.60M | 27.11M | 35.17M | 90.54M | 75.71M | 55.76M | 28.55M | 45.09M |
| Book Value | 61.05M | 78.17M | 94.72M | 35.20M | (16.55M) | (17.18M) | 38.23M | 18.96M | 35.80M | 52.06M | 90.19M | 64.46M |
| Return on Equity | -0.34 | -0.25 | -0.16 | -0.41 | N/A | N/A | -0.53 | -1.00 | -0.48 | -0.46 | -0.23 | 0.02 |
SENS News
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
SENS Launches Eversense 365, World's Only One-Year CGM in Europe
Senseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM System
Ralliant (NYSE:RAL) versus Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Head-To-Head Analysis
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) vs. Ralliant (NYSE:RAL) Financial Survey
Reviewing Ralliant (NYSE:RAL) & Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Ralliant (NYSE:RAL) Financial Analysis
Head to Head Survey: Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Ralliant (NYSE:RAL)
Analyzing Ralliant (NYSE:RAL) & Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)
Ralliant (NYSE:RAL) & Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Head to Head Comparison